Browsing Tag
Sai Life Sciences
2 posts
Sai Life Sciences (NSE: SAILIFE) Q2 FY26 profit doubles on CRDMO demand, high-value tech expansion
Sai Life Sciences profit doubled in Q2 FY26, driven by peptide, ADC, and oligo expansion. See how the CRDMO firm is gaining margin and investor traction.
Sai Life Sciences unveils cutting-edge Peptide Research Center to fuel biotech breakthroughs
Sai Life Sciences launches Peptide Research Center in Hyderabad to expand peptide therapeutics and R&D services. Learn how this impacts pharma innovation and investors.